A worldwide yearly survey of new data in adverse drug by J.K. Aronson (Eds.)

By J.K. Aronson (Eds.)

The uncomfortable side effects of gear Annual used to be first released in 1977. it's been constantly released seeing that then as a every year replace to the voluminous encyclopedia, Meyler's negative effects of substances. each one new Annual maintains to supply clinicians and scientific investigators with a competent and significant each year survey of latest information and tendencies within the zone of difficult drug reactions and interactions. a world staff of experts has contributed to the informative Annual through significantly examining it and via pointing to no matter what is deceptive. every one new Annual maintains to supply clinicians and clinical investigators with a competent and demanding every year survey of recent information and tendencies within the zone of difficult drug reactions and interactions. a world staff of experts has contributed to the informative Annual by way of significantly examining it and through pointing to no matter what is deceptive.

Show description

Read or Download A worldwide yearly survey of new data in adverse drug reactions PDF

Similar pharmacology books

Intelligent Drug Development: Trials and Errors in Clinical Research

Medical examine is seriously regulated and comprises coordination of diverse pharmaceutical-related disciplines. each one person trial contains contractual, regulatory, and ethics approval at each one website and in every one state. scientific trials became so complicated and govt requisites so stringent that researchers usually method trials too carefully, confident that the method is certain to be insurmountably advanced and riddled with roadblocks.

Desk Reference of Clinical Pharmacology

Because the e-book of the bestselling first variation of CRC table Reference of scientific Pharmacology, dramatic discoveries in molecular drugs in addition to swift technological advances have revolutionized the prognosis and ended in new drugs for use within the remedy of a vast diversity of human illnesses.

Rules and Guidance for Pharmaceutical Manufacturers and Distributors

Familiarly referred to as the "Orange Guide," this identify is a necessary reference paintings for all these interested in the manufacture or distribution of medications in or for Europe. it truly is compiled via the united kingdom drug regulatory physique, the MHRA, and brings jointly the eu and united kingdom assistance files and data on laws with regards to the manufacture and distribution of medications for human use.

Extra info for A worldwide yearly survey of new data in adverse drug reactions

Sample text

411 References 1. Aronson JK, Ferner RE. Joining the DoTS. New approach to classifying adverse drug reactions. BMJ 2003; 327: 1222–5. 2. Aronson JK, Ferner RE. Clarification of terminology in drug safety. Drug Saf 2005; 28(10): 851–70. 3. Ferner RE, Aronson JK. EIDOS: A mechanistic classification of adverse drug effects. Drug Saf 2010; 33(1): 13–23. 4. Callréus T. Use of the dose, time, susceptibility (DoTS) classification scheme for adverse drug reactions in pharmacovigilance planning. Drug Saf 2006; 29(7): 557–66.

Third-generation oral contraceptives: time to look again? [14] Singer N. Health concerns over popular contraceptives. New York Times; 25 September 2009. pagewanted=all (last accessed 28 April 2011). [15] Van Grootheest K, Vrieling T. Thromboembolism associated with the new contraceptive Yasmin. BMJ 2003; 326(7383): 257. [16] van Hylckama Vlieg A, Helmerhorst FM, Vanderbroucke JP, Doggen CJM, Rosendaal FR. The venous thrombotic risk of oral contraceptives, effects of oestrogen dose and progestogen type: results of the MEGA case–control study.

BMJ 2003; 326(7383): 257. [16] van Hylckama Vlieg A, Helmerhorst FM, Vanderbroucke JP, Doggen CJM, Rosendaal FR. The venous thrombotic risk of oral contraceptives, effects of oestrogen dose and progestogen type: results of the MEGA case–control study. BMJ 2009; 339: b2921. [17] Lidegaard , Lkkegaard E, Svendsen AL, Agger C. Hormonal contraception and risk of venous thromboembolism: national follow-up study. BMJ 2009; 339: b2890. [18] Dinger JC, Heinemann LAJ, KühlHabich D. The safety of a drospirenonecontaining oral contraceptive: final results from the European Active Surveillance study on Oral Contraceptives based on 142,475 women-years of observation.

Download PDF sample

Rated 4.72 of 5 – based on 35 votes